Radiopharm Theranostics, a clinical-stage biopharmaceutical company, has announced compelling results from a study examining the effectiveness of 68Ga-Trivehexin (68Ga-RAD 301) for imaging αvβ6-integrin expression in pancreatic cancer. Published in Frontiers in Nuclear Medicine, the research involved a cohort of 44 patients, marking the largest study of its kind to date. This advancement addresses critical challenges […]
Indegene Limited, a leading digital-first life sciences commercialization company, has unveiled a new global delivery center in Hyderabad, further cementing its position as a critical partner for the biopharma and medical technology industries. This strategic expansion, announced on 18 November 2024, comes as the pharmaceutical sector faces mounting pressure to innovate and modernize operations amidst […]
Elanco Animal Health Incorporated has bolstered its global supply chain by acquiring a contract manufacturing facility in Speke, United Kingdom, previously owned by TriRx Speke Ltd. The move ensures uninterrupted production of critical farm animal products, which contribute approximately $160 million to $180 million in annual revenue, predominantly from markets outside the United States. This […]
NavaDerm Partners, LLC, a leading dermatology management platform based in New York City, has sold its Dermatology and Surgery Associates (DSA) practice to Schweiger Dermatology Group. This strategic move highlights NavaDerm’s focus on strengthening its flagship practices while supporting the continued growth of Schweiger Dermatology Group, a dominant player in the Northeast region. NavaDerm was […]
Deccan Health Care Limited, a prominent player in the nutraceutical industry, has reported a remarkable performance for Q2 FY25, showcasing substantial growth across all key financial parameters. The company, listed on the Bombay Stock Exchange (BSE: 542248), revealed a 25% quarterly increase in revenue, reaching ₹1,882.1 lakhs, alongside a 27.5% rise in EBITDA and an […]
In a bold move to expand its reach in specialty healthcare, Cardinal Health has announced it will acquire significant assets in gastroenterology and diabetes care through two high-stakes deals worth a combined $3.9 billion. The U.S.-based pharmaceutical and healthcare giant is set to take a controlling interest in GI Alliance, the largest independent gastroenterology care […]
In a decisive move to maintain competition within the healthcare sector, the United States Department of Justice, in collaboration with attorneys general from Maryland, Illinois, New Jersey, and New York, filed a lawsuit on November 12, 2024, aiming to prevent UnitedHealth Group’s proposed $3.3 billion acquisition of Amedisys Inc. The lawsuit contends that this merger […]
In a shocking turn of events, genetic testing powerhouse 23andMe announced it will slash 40% of its workforce, or roughly 200 employees, in a bid to curb costs amid intensifying financial challenges. The company, once celebrated for democratizing DNA testing, has decided to shut down its ambitious therapeutics development program as part of a sweeping […]
Fortis Healthcare Limited, one of India’s leading healthcare service providers, announced a 12.3% year-on-year revenue growth for Q2 FY25, reaching INR 1,988 crore, with an impressive 31.9% rise in operating EBITDA to INR 435 crore. The financial gains are attributed to strong performance across both the hospital and diagnostic segments, according to Fortis. Hospital Business […]
Metropolis Healthcare Limited, one of India’s prominent diagnostic chains, has reported a significant year-on-year profit growth of 31.0% in Q2 FY2024-25. This sharp increase is attributed to rising patient volumes, boosted revenue per patient, and robust operational performance. The financial highlights reveal that the company’s revenue from operations reached INR 350 crores, marking a 13.4% […]
